Xenetic Biosciences (NASDAQ:XBIO) Stock Passes Below 50-Day Moving Average of $3.88

Xenetic Biosciences Inc (NASDAQ:XBIO) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $3.88 and traded as low as $3.69. Xenetic Biosciences shares last traded at $3.75, with a volume of 14,071 shares traded.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “neutral” rating on shares of Xenetic Biosciences in a research report on Tuesday, August 20th.

Xenetic Biosciences Price Performance

The business has a 50 day simple moving average of $3.87 and a 200-day simple moving average of $3.98. The stock has a market capitalization of $5.87 million, a price-to-earnings ratio of -1.30 and a beta of 2.24.

Xenetic Biosciences (NASDAQ:XBIO) last posted its earnings results on Tuesday, August 13th. The company reported ($0.83) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.83). Xenetic Biosciences had a negative return on equity of 51.05% and a negative net margin of 186.39%. The business had revenue of $0.73 million during the quarter, compared to analysts’ expectations of $0.54 million. As a group, equities analysts predict that Xenetic Biosciences Inc will post -1.01 earnings per share for the current year.

Xenetic Biosciences Company Profile

Xenetic Biosciences, Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas.